Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
32.32
+0.85 (2.70%)
At close: May 8, 2026, 4:00 PM EDT
32.21
-0.11 (-0.34%)
After-hours: May 8, 2026, 7:59 PM EDT
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $3.22 billion as of May 8, 2026. Its market cap has increased by 62.78% in one year.
Market Cap
3.22B
Enterprise Value
2.26B
1-Year Change
62.78%
Ranking
Category
Stock Price
$32.32
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $3.22B, an increase of 880.88%. That is a compound annual growth rate of 44.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 3.22B | 17.59% |
| Dec 31, 2025 | 2.74B | 38.60% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viking Therapeutics | 3.64B |
| Telix Pharmaceuticals | 3.62B |
| Tango Therapeutics | 3.32B |
| Arcus Biosciences | 3.19B |
| Erasca | 3.15B |
| Denali Therapeutics | 3.11B |
| Alumis | 3.01B |
| Dyne Therapeutics | 2.91B |